In the latest achievement for QuantWave's forecasting platform, the stock of PFIZER INC. successfully reached the price target as predicted....
Pfizer Inc. stock recently hit the price target forecast by QuantWave, resulting in a profit of 6.03%. The forecast signal was generated on June 18, 2025, with a price of $23....
On June 20, 2025, QuantWave forecasted a long signal for PFIZER INC., with a price of 23.97 $. The target price of 25.32 $ was reached on July 2, 2025, resulting in a profit of 5.63%....
On May 5, 2025, QuantWave, the automated forecasting platform, issued a long signal for PFIZER INC. (PFE) when the stock was trading at $23.42. Fast forward to July 2, 2025, PFIZER INC....
On May 2, 2025, QuantWave, the automated forecasting platform, issued a long signal for PFIZER INC. stock when it was trading at 23.75 $....
On May 28, 2025, QuantWave, the automated forecasting platform, issued a long signal for PFIZER INC.'s stock when it was priced at 23.18 $....
PFIZER INC. has successfully reached the price target forecast set by QuantWave, signaling a profitable long position. The forecast signal was issued on 2025-05-21 when the stock was at 23.04 $....
On May 22, 2025, QuantWave issued a forecast signal for PFIZER INC. stock, predicting a long position at a price of $23.04. The target was reached on June 10, 2025, with the stock price hitting $24....
Pfizer Inc. announced a new partnership with Acepodia to develop cutting-edge cancer treatments....
PFIZER INC. has successfully achieved the price target forecast set by QuantWave, with a profit of 7.0%. The forecast signal was issued on April 2, 2025, at a price of 24.24 $....
Consolidated Planning Corp, a prominent investment firm, has recently acquired 1842 shares of the pharmaceutical giant Amgen Inc. NASDAQ:AMGN....
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has been making significant strides in the pharmaceutical industry, driving growth and attracting investors....
Eli Lilly and Company (LLY) announced today a major investment of $4.5 billion in the establishment of a state-of-the-art medicine foundry for advanced drug manufacturing....
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has been making headlines recently with its groundbreaking innovations in the field of biotechnology....
Regeneron Pharmaceuticals Inc., a leading biotechnology company, announced its impressive financial results for the fourth quarter of 2024....